| Study samples | Prevalence in population$ |  | |||
---|---|---|---|---|---|---|
 | Control area | SMC area | Control area | SMC area | Prevalence ratio^ | p-value |
SMC/ non SMC (95% CI) | ||||||
Prevalence of parasitaemia: | 6/216 | 21/882 | 2.47 | 1.76 | 0.71 (0.23, 2.20) | 0.55 |
Prevalence of mutations | Â | Â | Â | Â | Â | Â |
dhfr triple (51, 59, 108) | 4/4 | 19/21 | 2.78 | 2.15 | 0.78 (0.30, 1.98) | 0.60 |
dhps-437 | 4/4 | 18/21 | 2.78 | 2.04 | 0.74 (0.28, 1.90) | 0.52 |
SP resistant mutant (dhfr triple + dhps 437) | 4/4 | 18/21 | 2.78 | 2.04 | 0.74 (0.28, 1.90) | 0.52 |
crt CVIET mutation | 2/5 | 8/22 | 1.11 | 0.87 | 0.78 (0.15, 4.09) | 0.77 |
mdr 86Y | 0/5 | 12/22 | 0 | 1.30 | - | - |
mdr 184F | 2/5 | 15/22 | 1.11 | 1.62 | 1.46 (0.27, 8.05) | 0.66 |
AQ resistant mutant (mdr 86Y + crt CVIET) | 0/5 | 5/22 | 0 | 0.54 | - | - |
SP resistant & AQ resistant | 0/4 | 5/21 | 0 | 0.57 | - | - |